Akari Therapeutics Plc (AKTX) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 19, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 19, 2026 filed Aug. 17, 2026 | Farag Kameel D. Interim CFO | $12,995 | 1,728 | +8% | No | |
|
|
||||||
| Aug. 5, 2026 filed July 16, 2026 | Farag Kameel D. Interim CFO | $12,995 | 1,130 | +6% | No | |
|
|
||||||
| July 17, 2026 filed July 7, 2026 | Patel Samir Rashmikant Director | $392,011 | 44,948 | — | No | |
|
|
||||||
| June 25, 2026 filed June 24, 2026 | Farag Kameel D. Interim CFO | $105,006 | 18,830 | +1161% | No | |
|
|
||||||
| June 25, 2026 filed June 24, 2026 | Gaslightwala Abizer CEO | $0 | 21,063 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free